APA

National Cancer Institute (U.S.), . (1970). Suppression of mammary hyperplastic nodule formation and pituitary prolactin secretion in mice induced by ergocornine or 2-bromo-ergocryptine. [Washington, D.C: .

Chicago

National Cancer Institute (U.S.), . 1970. Suppression of mammary hyperplastic nodule formation and pituitary prolactin secretion in mice induced by ergocornine or 2-bromo-ergocryptine. [Washington, D.C: .

Harvard

National Cancer Institute (U.S.), . (1970). Suppression of mammary hyperplastic nodule formation and pituitary prolactin secretion in mice induced by ergocornine or 2-bromo-ergocryptine. [Washington, D.C: .

MLA

National Cancer Institute (U.S.), . Suppression of mammary hyperplastic nodule formation and pituitary prolactin secretion in mice induced by ergocornine or 2-bromo-ergocryptine. [Washington, D.C: . 1970.